Henrik Lund
Director/Miembro de la Junta en Oslo Cancer Cluster NCE .
Perfil
Henrik Lund is currently the Director at Oslo Cancer Cluster NCE and MedCoast Scandinavia.
Previously, he was the Chief Executive Officer and Head-Investor Relations at NEL ASA in 2012 and the CEO and Investor Relations Officer at Bionor Pharma ASA in 2011.
Cargos activos de Henrik Lund
Empresas | Cargo | Inicio |
---|---|---|
Oslo Cancer Cluster NCE
Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway. | Director/Miembro de la Junta | 17/06/2011 |
MedCoast Scandinavia | Director/Miembro de la Junta | 17/06/2011 |
Antiguos cargos conocidos de Henrik Lund.
Empresas | Cargo | Fin |
---|---|---|
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Presidente | 15/08/2011 |
NEL ASA | Presidente | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NEL ASA | Producer Manufacturing |
Empresas privadas | 3 |
---|---|
Oslo Cancer Cluster NCE
Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway. | Commercial Services |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
MedCoast Scandinavia |
- Bolsa de valores
- Insiders
- Henrik Lund